WELCOME TO SIT ITALIA

Conferenza

New Implementation: Medical Sales Representatives

Laboratorio Farmaceutico SIT strengthens the relationship between Company and Doctor, with the implementation of its own network of medical representatives. 

This strategic change was strongly desired by SIT group, in order to offer a continuous service of accurate updating to the medical community.

The activities will be nationwide and will be addressed to both general practitioners and medical specialists.

SIT PHARMA is pleased to announce the acquisition of OSTIDIL-D3 and KEFORAL
SIT Pharma is pleased to announce the acquisition of DERINOX® from Therabel Lucien Pharma Sas
SIT Pharma is pleased to announce the acquisition of MIZOLLEN® from THERABEL HEALTHCARE LIMITED